NCT05524064View on ClinicalTrials.gov

FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases in the Thorax

NAActive, not recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 8, 2023

Primary Completion Date

May 1, 2027

Study Completion Date

May 1, 2027

Conditions
Bone Metastases in the Thorax
Interventions
RADIATION

FLASH Radiotherapy

A dose of 8 Gy delivered in a single fraction will be prescribed to the PTV, delivered with FLASH Radiotherapy (\>40 Gy/s).

Trial Locations (2)

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

61637

OSF Healthcare Saint Francis Medical Center, Peoria

All Listed Sponsors
lead

Varian, a Siemens Healthineers Company

INDUSTRY

NCT05524064 - FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases in the Thorax | Biotech Hunter | Biotech Hunter